---
title: Impact of diet and nutrition on cholesterol levels
videoId: 7gZt9DQqtZI
---

From: [[foundmyfitness]] <br/> 

Dr. Ronald Krauss, director of the atherosclerosis center at Children's Hospital Oakland Research Institute and an adjunct professor at the University of California, San Francisco, has played a significant role in changing the scientific understanding of cholesterol <a class="yt-timestamp" data-t="00:00:03">[00:00:03]</a>. His work involved developing an assay that differentiates between the various sizes of lipoproteins that carry cholesterol <a class="yt-timestamp" data-t="00:00:27">[00:00:27]</a>.

## Understanding Lipoprotein Particle Sizes and [[the_relationship_between_cholesterol_and_heart_disease | Heart Disease Risk]]

For decades, the common understanding was that there were two types of cholesterol: "good" cholesterol (high-density lipoproteins or HDL) and "bad" cholesterol (low-density lipoproteins or LDL) <a class="yt-timestamp" data-t="00:00:57">[00:00:57]</a>. However, research, including Dr. Krauss's, has revealed that the picture is much more complex, with various sizes and densities of these lipoproteins <a class="yt-timestamp" data-t="00:01:11">[00:01:11]</a>.

LDL cholesterol measurements in a standard lipid panel represent the summation of cholesterol within a spectrum of LDL particles <a class="yt-timestamp" data-t="00:01:42">[00:01:42]</a>. These particles range from very small and dense to large and buoyant <a class="yt-timestamp" data-t="00:01:48">[00:01:48]</a>. Dr. Krauss's methodology helped show that these different forms of LDL have very different metabolic and pathological properties <a class="yt-timestamp" data-t="00:02:07">[00:02:07]</a>.

*   **Small, Dense LDL**: Individuals with a higher [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] or evidence of [[the_relationship_between_cholesterol_and_heart_disease | heart disease]] tend to have more of the smaller and more dense LDL particles <a class="yt-timestamp" data-t="00:02:46">[00:02:46]</a>. Even though these smaller particles carry less cholesterol, they have a greater tendency to accumulate in the artery wall, bind more tightly to artery tissue, and get oxidized more rapidly <a class="yt-timestamp" data-t="00:03:49">[00:03:49]</a>. They also have less affinity for the LDL receptor, meaning they are less efficiently removed from the blood by the liver and thus circulate longer, increasing their opportunity to interact adversely with arteries <a class="yt-timestamp" data-t="00:26:41">[00:26:41]</a>.
*   **Large, Buoyant LDL**: Healthier individuals tend to have more of the larger, more buoyant LDL particles <a class="yt-timestamp" data-t="00:03:02">[00:03:02]</a>. These particles, despite having more cholesterol, do not possess the same pathological features as small LDL <a class="yt-timestamp" data-t="00:04:29">[00:04:29]</a>. Large buoyant LDL is important for cells needing to repair damage, like cell membranes <a class="yt-timestamp" data-t="00:05:01">[00:05:01]</a>.

The origin of LDL particles is in the liver, which packages lipids, cholesterol, triglycerides, and phospholipids into spherical lipoprotein particles <a class="yt-timestamp" data-t="00:06:25">[00:06:25]</a>. These are primarily triglyceride-rich particles (very-low-density lipoproteins or VLDL), with cholesterol acting as a "passenger" <a class="yt-timestamp" data-t="00:06:52">[00:06:52]</a>. As triglycerides are broken down and used by the body, these particles shrink, losing triglyceride but retaining most cholesterol, thus transforming from large VLDL into smaller, denser LDL particles <a class="yt-timestamp" data-t="00:08:26">[00:08:26]</a>. This inefficient removal of LDL from the blood in humans, compared to most other species, contributes to its accumulation and susceptibility to [[the_relationship_between_cholesterol_and_heart_disease | heart disease]] <a class="yt-timestamp" data-t="00:10:07">[00:10:07]</a>.

The concept of "atherogenic dyslipidemia" describes a collection of interrelated traits linked to [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]]: small LDL, low HDL (especially HDL cholesterol), and high levels of triglyceride-rich lipoproteins and their remnants <a class="yt-timestamp" data-t="00:13:14">[00:13:14]</a>. This collective is considered a significant measure of [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] in the population <a class="yt-timestamp" data-t="00:13:54">[00:13:54]</a>. Small LDL is almost certainly a causative feature of the disease associated with risk <a class="yt-timestamp" data-t="00:14:10">[00:14:10]</a>.

### Inflammation and Lipoprotein Metabolism

Inflammation plays a major role in [[the_relationship_between_cholesterol_and_heart_disease | heart disease]], converting benign cholesterol deposits into dangerous plaques <a class="yt-timestamp" data-t="00:18:01">[00:18:01]</a>. The liver's production of VLDL (triglyceride-rich particles) is influenced by inflammation, potentially serving a role in host defense <a class="yt-timestamp" data-t="00:18:47">[00:18:47]</a>. Cytokines, such as TNF-alpha and interferon, stimulate VLDL secretion by the liver, rapidly increasing lipid synthesis and export <a class="yt-timestamp" data-t="00:23:22">[00:23:22]</a>.

Endotoxins (lipopolysaccharides or LPS) from gut bacteria can bind to lipoproteins, including VLDL and LDL <a class="yt-timestamp" data-t="00:17:05">[00:17:05]</a>. This binding may be a protective mechanism to sequester LPS <a class="yt-timestamp" data-t="00:24:30">[00:24:30]</a>. If LDL clearance is increased (e.g., by statins), LPS levels can be lowered, consistent with lipoproteins helping to transport and remove LPS <a class="yt-timestamp" data-t="00:24:54">[00:24:54]</a>. Since small LDL particles are cleared less efficiently, any LPS bound to them could circulate longer, potentially contributing to atherosclerosis <a class="yt-timestamp" data-t="00:27:50">[00:27:50]</a>.

## [[Impact of diet and lifestyle on cholesterol and heart health | Dietary Factors]] and Cholesterol Levels

### Dietary Cholesterol
The human body is capable of manufacturing its own cholesterol in virtually all tissues <a class="yt-timestamp" data-t="00:05:42">[00:05:42]</a>. The body also regulates the absorption of dietary cholesterol <a class="yt-timestamp" data-t="00:05:51">[00:05:51]</a>. Research, including Dr. Krauss's work with the Institute of Medicine, has shown that the effect of dietary cholesterol on blood cholesterol is very small, almost unmeasurable, for most people <a class="yt-timestamp" data-t="00:31:05">[00:31:05]</a>. This finding led to a change in U.S. dietary guidelines, abandoning the recommendation to keep cholesterol intake below 300 milligrams per day <a class="yt-timestamp" data-t="00:31:55">[00:31:55]</a>. Despite this, the outdated idea that eating cholesterol-rich foods like eggs significantly raises blood cholesterol persists among the public and some physicians <a class="yt-timestamp" data-t="00:32:24">[00:32:24]</a>.

### Saturated Fat
The [[Impact of diet and lifestyle on cholesterol and heart health | dietary impact]] on [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] is more complex than just its effects on blood cholesterol <a class="yt-timestamp" data-t="00:33:12">[00:33:12]</a>. While saturated fatty acids can raise blood LDL levels <a class="yt-timestamp" data-t="00:33:31">[00:33:31]</a>, studies by Dr. Krauss's group showed that the form of LDL that increases with saturated fat intake is primarily the *large* LDL, not the small, dense LDL <a class="yt-timestamp" data-t="00:33:52">[00:33:52]</a>. This finding led Dr. Krauss to question the strong relationship between saturated fat and [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] for the general population <a class="yt-timestamp" data-t="00:34:03">[00:34:03]</a>. More recent reports have supported the absence of a strong, direct relationship between saturated fat itself and [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] <a class="yt-timestamp" data-t="00:34:58">[00:34:58]</a>. The *food context* in which saturated fat is consumed may be more important; for instance, processed red meat containing saturated fat may have adverse effects on [[the_relationship_between_cholesterol_and_heart_disease | heart disease]] and [[diet_and_lifestyle_impact_on_longevity | life expectancy]], but the saturated fat might not be the primary culprit <a class="yt-timestamp" data-t="00:35:14">[00:35:14]</a>.

### Carbohydrates
The long-standing public health message promoting low-fat diets led to an unintended consequence: an increase in carbohydrate intake <a class="yt-timestamp" data-t="00:37:02">[00:37:02]</a>. Dr. Krauss's research found that a low-fat diet could actually make LDL particles smaller, the opposite of what was expected <a class="yt-timestamp" data-t="00:38:21">[00:38:21]</a>. This effect was linked to the substitution of carbohydrates <a class="yt-timestamp" data-t="00:38:46">[00:38:46]</a>. High-carbohydrate diets can promote the liver's production of VLDL particles that lead to small, dense LDL <a class="yt-timestamp" data-t="00:38:57">[00:38:57]</a>.

High carbohydrate intake, particularly simple sugars like fructose (a component of table sugar and added sugars), pushes lipoprotein metabolism towards atherogenic dyslipidemia, characterized by high triglycerides, small LDL, and lower HDL <a class="yt-timestamp" data-t="00:39:03">[00:39:03]</a>. While all carbohydrates have this potential, sugars, especially fructose, are considered the most potent <a class="yt-timestamp" data-t="00:40:19">[00:40:19]</a>.

It is important to distinguish between sugars in processed foods and those in whole fruits. Fructose in fruits, in the context of fiber and other natural packaging, is absorbed more slowly and in smaller doses compared to concentrated added sugars in beverages like soda <a class="yt-timestamp" data-t="00:41:12">[00:41:12]</a>.

While there is debate about the direct link between glycemic index (how quickly a food raises blood sugar) and lipoprotein metabolism or [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]], focusing on reducing added sugars is a widely accepted [[dietary_practices_and_metabolic_health | dietary recommendation]] <a class="yt-timestamp" data-t="00:41:14">[00:41:14]</a>.

### Combinatorial Effects of Diet
The combined effect of added sugars and saturated fat (e.g., in foods like a "Big Mac" with a milkshake) is hypothesized to be particularly detrimental to health, but this area of [[Impact of diet and lifestyle on cholesterol and heart health | nutrition research]] is expensive and underfunded <a class="yt-timestamp" data-t="00:45:03">[00:45:03]</a>.

## Diet vs. Statins in Modulating [[the_relationship_between_cholesterol_and_heart_disease | Heart Disease Risk]]
While Dr. Krauss is a strong believer in [[Impact of diet and lifestyle on cholesterol and heart health | lifestyle intervention]], including diet and exercise, for promoting overall health and reducing [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] <a class="yt-timestamp" data-t="00:56:38">[00:56:38]</a>, there is limited rigorous evidence from large-scale, long-term randomized control trials to definitively prove that specific [[Impact of diet and lifestyle on cholesterol and heart health | dietary modifications]] reduce [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] <a class="yt-timestamp" data-t="00:55:06">[00:55:06]</a>. This is partly due to the difficulty and cost of conducting such studies, issues with patient compliance over time, and the relatively smaller average effects of diet compared to pharmaceuticals <a class="yt-timestamp" data-t="00:55:23">[00:55:23]</a>.

Statins, on the other hand, have robust evidence from large industry-funded trials demonstrating their effectiveness in lowering LDL and reducing [[the_relationship_between_cholesterol_and_heart_disease | heart disease risk]] by 30-40% <a class="yt-timestamp" data-t="00:53:14">[00:53:14]</a>. Statins primarily work by increasing LDL receptor activity, which enhances the clearance of LDL particles from the blood, particularly the larger ones <a class="yt-timestamp" data-t="00:51:48">[00:51:48]</a>. While statins are less effective at clearing the very smallest LDL particles due to their lower receptor affinity, their overall LDL-lowering effect is undeniable <a class="yt-timestamp" data-t="00:52:11">[00:52:11]</a>.

Despite the benefits, Dr. Krauss highlights concerns about statin overprescription, especially for primary prevention in healthy individuals, and potential adverse effects such as muscle issues and an increased risk of developing type 2 diabetes <a class="yt-timestamp" data-t="01:00:20">[01:00:20]</a>. This risk can be significant, particularly in women, where up to 30-40% of otherwise healthy women might develop type 2 diabetes on statins <a class="yt-timestamp" data-t="01:02:59">[01:02:59]</a>.

Dr. Krauss advocates for the use of more refined laboratory tools, like lipoprotein particle measurements, to better identify individuals who are most likely to benefit from statins and to monitor treatment efficacy, rather than solely relying on total LDL cholesterol <a class="yt-timestamp" data-t="01:04:52">[01:04:52]</a>. His developed test, using ion mobility to count particles by size, provides highly refined lipoprotein analysis <a class="yt-timestamp" data-t="01:09:32">[01:09:32]</a>. While this test is not yet universally adopted due to historical confusion and standardization issues, its cost has decreased, making it more accessible <a class="yt-timestamp" data-t="01:08:55">[01:08:55]</a>. It is particularly valuable for individuals with borderline LDL cholesterol levels, as particle measurements better discriminate [[the_relationship_between_cholesterol_and_heart_disease | heart disease patients]] from the general population <a class="yt-timestamp" data-t="01:12:22">[01:12:22]</a>.